Efficacy of an Innovative Aerosol Foam Formulation of Fixed Combination Calcipotriol plus Betamethasone Dipropionate in Patients with Psoriasis Vulgaris

BACKGROUND AND OBJECTIVE: The antipsoriatic effect of an innovative aerosol foam formulation of fixed combination calcipotriol 50 μg/g (as hydrate; Cal) and betamethasone 0.5 mg/g (as dipropionate; BD) was explored in order to compare the effect with that of the first-line treatment Cal/BD ointment....

Descripción completa

Detalles Bibliográficos
Autores principales: Queille-Roussel, Catherine, Olesen, Martin, Villumsen, John, Lacour, Jean-Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368848/
https://www.ncbi.nlm.nih.gov/pubmed/25708531
http://dx.doi.org/10.1007/s40261-015-0269-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368848/
https://www.ncbi.nlm.nih.gov/pubmed/25708531
http://dx.doi.org/10.1007/s40261-015-0269-7

Ejemplares similares